Previous Next
Elevated levels of lipoproteins containing apoB are a risk factor for atherosclerotic cardiovascular disease, including peripheral arterial disease and myocardial infarction. In this study, Danish researchers analyzed levels of apoB-containing lipoproteins, residual cholesterol and LDL-cholesterol in 93,461 statin-naive patients at baseline. During follow-up of up to 15 years, 1,207 patients developed CAD, 522 developed chronic ischemic limb disease and 2,202 developed myocardial infarction. In the association between increased apoB and increased risk of peripheral arterial disease, residual cholesterol and LDL-cholesterol accounted for 73% and 8% respectively. 

Source(s) :
Benjamin N Wadström et al. Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study. Arterioscler Thromb Vasc Biol. 2024 Mar 21. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...